2.A randomized prospective study comparing acute toxicity, compliance and objective response rate between simultaneous integrated boost and sequential intensity-modulated radiotherapy for locally advanced head and neck cancer
Akanksha GROVER ; Tej Prakash SONI ; Nidhi PATNI ; Dinesh Kumar SINGH ; Naresh JAKHOTIA ; Anil Kumar GUPTA ; Lalit Mohan SHARMA ; Shantanu SHARMA ; Ravindra Singh GOTHWAL
Radiation Oncology Journal 2021;39(1):15-23
Purpose:
Intensity-modulated radiotherapy (IMRT) provides higher dose to target volumes and limits the dose to normal tissues. IMRT may be applied using either simultaneous integrated boost (SIB-IMRT) or sequential boost (SEQ-IMRT) technique. The objectives of this study were to compare acute toxicity and objective response rates between SIB-IMRT and SEQ-IMRT in patients with locally advanced head and neck cancer.
Materials and Methods:
Total 110 patients with locally advanced carcinoma of oropharynx, hypopharynx, and larynx were randomized equally into the two arms (SIB-IMRT vs. SEQ-IMRT). Patients in SIB-IMRT arm received dose of 66 Gy in 30 fractions, 5 days a week, over 6 weeks. SEQ-IMRT arm’s patients received 70 Gy in 35 fractions over 7 weeks. Weekly concurrent cisplatin chemotherapy was given in both arms. Patients were assessed for acute toxicities during the treatment and for objective response at 3 months after the radiotherapy.
Results:
Grade 3 dysphagia was significantly more with SIB-IMRT compared to SEQ-IMRT (72% vs. 41.2%; p = 0.006) but other toxicities including mucositis, dermatitis, xerostomia, weight-loss, incidence of nasogastric tube intubation and hospitalization for supportive management were similar in both the arms. Patients in SIB-IMRT arm showed better treatment-compliance and had significantly less treatment-interruption compared to SEQ-IMRT arm (p = 0.028). Objective response rates were similar in both the arms (p = 0.783).
Conclusion
Concurrent chemoradiation with SIB-IMRT for locally advanced head and neck cancer is well-tolerated and results in better treatment-compliance, similar objective response rates, comparable incidence of mucositis and higher incidence of grade 3 dysphagia compared to SEQ-IMRT.
3.A randomized prospective study comparing acute toxicity, compliance and objective response rate between simultaneous integrated boost and sequential intensity-modulated radiotherapy for locally advanced head and neck cancer
Akanksha GROVER ; Tej Prakash SONI ; Nidhi PATNI ; Dinesh Kumar SINGH ; Naresh JAKHOTIA ; Anil Kumar GUPTA ; Lalit Mohan SHARMA ; Shantanu SHARMA ; Ravindra Singh GOTHWAL
Radiation Oncology Journal 2021;39(1):15-23
Purpose:
Intensity-modulated radiotherapy (IMRT) provides higher dose to target volumes and limits the dose to normal tissues. IMRT may be applied using either simultaneous integrated boost (SIB-IMRT) or sequential boost (SEQ-IMRT) technique. The objectives of this study were to compare acute toxicity and objective response rates between SIB-IMRT and SEQ-IMRT in patients with locally advanced head and neck cancer.
Materials and Methods:
Total 110 patients with locally advanced carcinoma of oropharynx, hypopharynx, and larynx were randomized equally into the two arms (SIB-IMRT vs. SEQ-IMRT). Patients in SIB-IMRT arm received dose of 66 Gy in 30 fractions, 5 days a week, over 6 weeks. SEQ-IMRT arm’s patients received 70 Gy in 35 fractions over 7 weeks. Weekly concurrent cisplatin chemotherapy was given in both arms. Patients were assessed for acute toxicities during the treatment and for objective response at 3 months after the radiotherapy.
Results:
Grade 3 dysphagia was significantly more with SIB-IMRT compared to SEQ-IMRT (72% vs. 41.2%; p = 0.006) but other toxicities including mucositis, dermatitis, xerostomia, weight-loss, incidence of nasogastric tube intubation and hospitalization for supportive management were similar in both the arms. Patients in SIB-IMRT arm showed better treatment-compliance and had significantly less treatment-interruption compared to SEQ-IMRT arm (p = 0.028). Objective response rates were similar in both the arms (p = 0.783).
Conclusion
Concurrent chemoradiation with SIB-IMRT for locally advanced head and neck cancer is well-tolerated and results in better treatment-compliance, similar objective response rates, comparable incidence of mucositis and higher incidence of grade 3 dysphagia compared to SEQ-IMRT.
4.Impact of three dimensional printing in orthopedics
Kumar LALIT ; Haleem ABID ; Mohd.Javaid
Global Health Journal 2021;5(4):178-182
The primary objective of this article is to explore effects of latest development in the area of three dimensional(3D) printing & to assess its abilities,and further undertake helpful reporting.Here the focus is to assess ad-vantages of 3D printing in orthopedics and analyze how 3D printed models help solve complex 3D orthopedics distortions.This study identified that 3D models manufactured by 3D printing models reduce medical parts de-velopment cost and surgical planning time.Integrating 3D printing with orthopaedics helps in understanding the conditions of problems and achieving the operation successfully.This technology can enable doctors/surgeons to design,produce,recreate and plan operations more accurately,carefully,and economically.3D models can assist specialists with a visual comprehension of the patient-particular pathology and life structures.Innovation in 3D printing initiated a scaffold for the virtual outline and execution of medical procedures.This research proposes the utilisation of 3D printers as an elective procedure for the fabrication of parts.It empowers surgeons/patients for better training,education and research.In the future,there is a foreseeable expansion of additive manufacturing in orthopedics.
5.COVID-19 - A Review of the Impact it has made on Supportive and Palliative Care Services Within a Tertiary Hospital and Cancer Centre in Singapore.
Shirlynn HO ; Yung Ying TAN ; Shirlyn Hui Shan NEO ; Qingyuan ZHUANG ; Min CHIAM ; Jamie Xuelian ZHOU ; Natalie Liling WOONG ; Guozhang LEE ; Lalit Kumar Radha KRISHNA
Annals of the Academy of Medicine, Singapore 2020;49(7):489-495
6.Prospects to the formation and control of potential dimer impurity E of pantoprazole sodium sesquihydrate
Awasthi Kumar ARUN ; Kumar LALIT ; Tripathi PUNIT ; Golla MADHAVA ; Reddy Suresh CIRANDUR ; Kumar PRAMOD
Journal of Pharmaceutical Analysis 2019;9(3):170-177
Pantoprazole sodium, a substituted benzimidazole derivative, is an irreversible proton pump inhibitor which is primarily used for the treatment of duodenal ulcers, gastric ulcers, and gastroesophageal reflux disease (GERD). The monographs of European Pharmacopoeia (Ph. Eur.) and United States Pharmaco-poeia (USP) specify six impurities, viz.; impurities A, B, C, D, E and F, respectively for its active phar-maceutical ingredient (API). The identification and synthesis of all impurities except impurity E are well described in the literature; however, there is no report related to impurity E. The prospects to the for-mation and controlling of impurity E up to ≤0.03% in the synthesis of pantoprazole sodium sesquihydrate (PAN) were discussed in detail for the first time. The present work described the journey towards the successful development of an optimal preparation procedure of dimer impurity E. The most plausible mechanism involved in the formation of impurity E has been proposed.
7.Status of Indian medicinal plants in the International Union for Conservation of Nature and the future of Ayurvedic drugs: Shouldn't think about Ayurvedic fundamentals?
Deepak Kumar SEMWAL ; Ashutosh CHAUHAN ; Ankit KUMAR ; Sonali ASWAL ; Ruchi Badoni SEMWAL ; Abhimanyu KUMAR
Journal of Integrative Medicine 2019;17(4):238-243
The present market for herbal drugs is estimated about ₹40 billion, which is expected to increase by 16% in next 3-4 years. The current production of many Ayurvedic herbs is less than their market demand, which incentivizes adulteration in the Ayurvedic drug supply chain. The present work aims to highlight the most used Ayurvedic plants that have been listed in the International Union for Conservation of Nature's "red list" of endangered or vulnerable plants. The future of Ayurvedic medicines from these listed plants is uncertain, as the collection of herbs from their natural habitat is prohibited and their cultivation does not meet market demands. Many of these plants, such as Taxus baccata and T. wallichiana, are endangered and are only grown in their natural habitats; their cultivation in other areas is impractical. This is the present state, and will worsen as demand continues to grow, with increasing populations and increasing adoption of this system of medicine. It is possible that in coming years most of the Ayurvedic drugs will be adulterated, and will cause only side effects rather than the therapeutic effects. The Ayurvedic fundamentals are under-explored areas where the Ayurvedic practitioners and research scientists can work together. The scientific work on the basic principles will unravel many unknown or little-known facts of this ancient science. Hence, the present review emphasizes the conservation of Ayurvedic herbs, minimization of the use of medicinal plants and the promotion of the research based on Ayurvedic fundamentals.
8.Distancing sedation in end-of-life care from physician-assisted suicide and euthanasia.
Tze Ling Gwendoline Beatrice SOH ; Lalit Kumar Radha KRISHNA ; Shin Wei SIM ; Alethea Chung Peng YEE
Singapore medical journal 2016;57(5):220-227
Lipuma equates continuous sedation until death (CSD) to physician-assisted suicide/euthanasia (PAS/E) based on the premise that iatrogenic unconsciousness negates social function and, thus, personhood, leaving a patient effectively 'dead'. Others have extrapolated upon this position further, to suggest that any use of sedation and/or opioids at the end of life would be analogous to CSD and thus tantamount to PAS/E. These posits sit diametrically opposite to standard end-of-life care practices. This paper will refute Lipuma's position and the posits borne from it. We first show that prevailing end-of-life care guidelines require proportional and monitored use of sedatives and/or opioids to attenuate fears that the use of such treatment could hasten death. These guidelines also classify CSD as a last resort treatment, employed only when symptoms prove intractable, and not amenable to all standard treatment options. Furthermore, CSD is applied only when deemed appropriate by a multidisciplinary palliative medicine team. We also show that empirical data based on local views of personhood will discount concerns that iatrogenic unconsciousness is tantamount to a loss of personhood and death.
Analgesics, Opioid
;
therapeutic use
;
Attitude of Health Personnel
;
Death
;
Deep Sedation
;
ethics
;
Ethics, Medical
;
Euthanasia
;
ethics
;
legislation & jurisprudence
;
Humans
;
Hypnotics and Sedatives
;
therapeutic use
;
Palliative Care
;
ethics
;
Personhood
;
Philosophy, Medical
;
Practice Guidelines as Topic
;
Suicide, Assisted
;
ethics
;
legislation & jurisprudence
;
Terminal Care
;
ethics
;
Unconsciousness
9.Embolization of the Device to the Left Pulmonary Artery after the Interventional Closure of Ruptured Sinus of Valsalva Aneurysm.
Lalit Kumar CHOUDHRY ; Vinay M RAO ; Birla Roy GNANAMUTHU ; Vishal AGRAWAL ; Ravi SHANKAR ; Ram PRASATH
The Korean Journal of Thoracic and Cardiovascular Surgery 2015;48(3):202-205
Formation of an aneurysm in the sinus of Valsalva of the aortic root is usually due to an area of congenital weakness in its wall. This aneurysm may progressively dilate and rupture into any of the cardiac chambers or into the pericardial cavity. Though this is conventionally treated by surgery, interventional therapy using various closure devices is becoming more common. Embolization of these closure devices may occur. We report a case of embolization of such a device into the left pulmonary artery which during surgical retrieval, unmasked the hidden ventricular septal defect (VSD). Therefore one has to be cautious while making a diagnosis of rupture of the sinus of Valsalva of right coronary sinus without VSD.
Aneurysm*
;
Coronary Sinus
;
Diagnosis
;
Heart Septal Defects, Ventricular
;
Pulmonary Artery*
;
Rupture
;
Sinus of Valsalva*
10.Subacute posttraumatic ascending myelopathy: A case report and review of literature.
Mukul MOHINDRA ; V-K GAUTAM ; Lalit MAINI ; Santosh KUMAR ; Saurabh VERMA
Chinese Journal of Traumatology 2015;18(1):48-50
Subacute posttraumatic ascending myelopathy is a rare disorder, unrelated to syrinx formation or mechanical instability, which may gradually emerge within the first 1-2 weeks after a spinal cord injury and may lead to diagnostic and prognostic dilemmas. We present a case of 24-year-old female with unstable wedge compression fracture of L1 vertebrae with signal changes in the upper lumbar cord causing complete paraplegia below D9 with bladder and bowel involvement. In the subsequent week, she developed a delayed progressively increasing neurological deficit with cord signal abnormality on MRI extending cephalad from the injury site to the upper dorsal cord. The patient had no initial clinical improvement initially but showed a delayed recovery over months.
Adult
;
Female
;
Humans
;
Spinal Cord Diseases
;
etiology
;
therapy
;
Spinal Cord Injuries
;
complications
;
Spinal Fractures
;
complications

Result Analysis
Print
Save
E-mail